glaucoma
Conditions
Interventions
experimental group/control group:subconjunctival Ologen implantation
Sponsors
West China Hospital of Sichuan University
Eligibility
Sex/Gender
All
Age
35 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) age 35 to 75; (2) phakic eyes with primary glaucoma which are in maximal tolerated medical therapy andIOP?18 mmHg,has been confirmed twice before inclusion; (3) best corrected visual acuity no less than 20/80; (4) subjects must sign informed consent; (5) subjects willing to cooperate to complete the follow-up after surgery.
Exclusion criteria
Exclusion criteria: (1) discernable congenital anomaly; (2) secondary glaucoma; (3) other disease which may effect IOP of subject eyes; (4) subjects who have undergone hematodialysis or peritoneal dialysis; (5) laser retinal treatment anterior to thevortex vein ampullae or retinal cryotherapy(retinal holes anterior to thevortex vein ampullae refer to less than two quadrants),laser treatment or surgery on subject eyes; (6) proliferative or non-proliferative retinopathy; (7) expanded pupil diameter less than 2mm; (8) field loss attribute to other conditions except for glaucoma; (9) field deep sclerectomy procedures on subject eyes.for example: leakage of eye balls because of excessive drainage or barely no drainage because of not enough depth in sclerectomy; (10) patients who may need MMC in trabeculectomy; (11) allergic to porcine -derived collagen; (12) pregnant or plan to become pregnant or in lactation period.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| intraocular pressure;best corrected visual acuity;success rate of surgery;morphology of blebs;compliactions;visual fields; | — |
Countries
China
Contacts
Public ContactTang Li
Outcome results
None listed